Detalhe da pesquisa
1.
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
J Biol Chem
; 299(7): 104883, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269947
2.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116523
3.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
4.
Persistent imbalance, anti-apoptotic, and anti-inflammatory signature of circulating C-C chemokines and cytokines in patients with paroxysmal nocturnal hemoglobinuria.
Cytokine
; 150: 155780, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896730
5.
Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.
Int J Mol Sci
; 21(16)2020 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32806528
6.
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).
BMC Cancer
; 15: 508, 2015 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26152663
7.
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.
Hemasphere
; 8(3): e56, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38486859
8.
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.
Blood Adv
; 8(8): 2020-2029, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231126
9.
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Leukemia
; 38(5): 1072-1080, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548962
10.
Identification and Pathogenicity of Fusarium Isolated from Soybean in Poland.
Pathogens
; 12(9)2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37764970
11.
Antifungal Potency of Amaranth Leaf Extract: An In Vitro Study.
Plants (Basel)
; 12(8)2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37111946
12.
Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
J Hematop
; 16(1): 39-47, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175371
13.
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Clin Lymphoma Myeloma Leuk
; 23(1): e19-e26, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396583
14.
Prognostic Impact of Copy Number Alterations' Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy.
Cancers (Basel)
; 15(22)2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001691
15.
Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment.
Pol Arch Intern Med
; 132(6)2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699625
16.
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
Oncogene
; 41(11): 1600-1609, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091682
17.
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Clin Lymphoma Myeloma Leuk
; 22(6): 405-415, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933827
18.
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG).
Cancers (Basel)
; 13(16)2021 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439342
19.
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Cell Death Dis
; 11(11): 956, 2020 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159047
20.
Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG).
Leuk Lymphoma
; 61(3): 588-603, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661339